{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigfgonzo4szemmfjxvm5tv6xuys5tvrayditl736bgeqvayn2pjwa",
    "uri": "at://did:plc:f6ki4c3jnuftcdpjsmnj64jn/app.bsky.feed.post/3mmx6jeuz3qw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigvhizwi2bf67tlr7z7nsxd23gezj3czqak5aa3scbzyszxphzxni"
    },
    "mimeType": "image/jpeg",
    "size": 220912
  },
  "path": "/category/world/who-identifies-ebola-treatments-vaccines-be-tested-in-trials-amid-outbreak",
  "publishedAt": "2026-05-28T21:34:48.000Z",
  "site": "https://japantoday.com",
  "textContent": "The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including ‌Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab and Gilead Sciences' antiviral remdesivir.\nThe WHO…",
  "title": "WHO identifies Ebola treatments, urgesvaccines be tested in trials"
}